Colorectal Cancer Screening
Percentage of patients 50-75 years of age who had appropriate screening for colorectal cancer.
Date Reviewed: January 27, 2022
Do Not Support: Uncertain Validity
Individual Clinician
Support
Group/Practice
Health Plan
Measure Info
MIPS 113NQF 0034CMS 113NQF EndorsedCQMC Core Measure
Measure Type:
Process
Measure Steward:
National Committee for Quality Assurance
Clinical Topic Area:
Cancer Screening
Effective Clinical Care
Prevention and Wellness
Care Setting:
Outpatient
Data Source:
Claims
Electronic Health Records
Registry
Colorectal cancer screening is an important clinical area. It is critical to improve access to evidence-based tests to make a meaningful clinical impact. These evidence-based tests should be clearly identified as not all tests have validity to support their use as stand-alone screening tests. The PMC recommends modifying the numerator to include only the types of tests that qualify as colorectal cancer screening, consistent with current guidelines. It would also be beneficial to extend the numerator time interval for performing the colonoscopy from nine years to ten years to ensure the exam is ordered and performed adequately.